We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+2.64%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.49B
AUM Growth
-$20.8M
Cap. Flow
-$39.5M
Cap. Flow %
-2.66%
Top 10 Hldgs %
46.58%
Holding
135
New
2
Increased
16
Reduced
37
Closed
6

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$5.09M
2
MSFT icon
Microsoft
MSFT
+$4.03M
3
V icon
Visa
V
+$2.27M
4
NVO
Novo Nordisk
NVO
+$1.24M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$981K

Top Sells

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$15.7M
2
META icon
Meta Platforms (Facebook)
META
+$6.33M
3
INTC icon
Intel
INTC
+$5.53M
4
EBAY icon
eBay
EBAY
+$4.55M
5
SNPS icon
Synopsys
SNPS
+$2.68M

Sector Composition

Rank Sector Weight
1 Technology 44.99%
2 Communication Services 15.72%
3 Healthcare 14.39%
4 Consumer Discretionary 11.2%
5 Financials 10.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTRS icon
126
Viatris
VTRS
$20.8B
$379K 0.03%
32,607
+14,487
+80% +$167K
BWXT icon
127
BWX Technologies
BWXT
$14.4B
$326K 0.02%
+3,000
New +$298K
VRNT
128
DELISTED
Verint Systems
VRNT
$317K 0.02%
12,498
– –
ENPH icon
129
Enphase Energy
ENPH
$4.63B
$257K 0.02%
2,270
– –
BIIB icon
130
Biogen
BIIB
$30.9B
– –
-6,190
Closed -$1.43M
HUM icon
131
Humana
HUM
$43.9B
– –
-4,883
Closed -$1.82M
INTC icon
132
Intel
INTC
$413B
– –
-178,476
Closed -$5.53M
IRWD icon
133
Ironwood Pharmaceuticals
IRWD
$586M
– –
-61,384
Closed -$400K
PGNY icon
134
Progyny
PGNY
$2.46B
– –
-52,150
Closed -$1.49M
2 3 4 5
6

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Oak Associates held 135 positions worth $1.49B, down 1.4% from $1.51B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Oak Associates's Q3 2024 filing shows 2 new, 16 increased, 37 reduced and 6 closed positions. Its largest new stake was Novo Nordisk: 9,283 shares worth $1.11M. The largest sale was KLA, an estimated $15.7M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, down from 46% a quarter earlier, followed by Communication Services and Healthcare.

  • Oak Associates's largest Q3 2024 buy was Novo Nordisk: 9,283 shares worth $1.11M.
  • Oak Associates added most to Pfizer in Q3 2024, an estimated $5.09M increase.
  • Oak Associates's biggest Q3 2024 reduction was KLA, cutting an estimated $15.7M.
  • Oak Associates fully exited Intel in Q3 2024, selling an estimated $5.53M.
  • Oak Associates's ten largest holdings make up 47% of its $1.49B portfolio in Q3 2024.
  • Oak Associates opened 2 new positions and closed 6 in Q3 2024.
  • Oak Associates's portfolio value fell 1.4% quarter-over-quarter to $1.49B.

Based on Oak Associates's 13F filing for Q3 2024, filed 12 Nov 2024.